In just six years, Sanoptis has emerged as a formidable force in European ophthalmology, becoming the largest player in Germany and Switzerland. Founded in 2018 by Dr. Volker Wendel and Carsten Horn, the Swiss-based group has grown to over 400 locations across six countries, pioneering a unique model that supports local ophthalmologists while integrating them into a larger network. Now under the ownership of Group Bruxelles Lambert, following initial backing by Telemos Capital, Sanoptis is poised for further expansion.

Don’t miss Dr. Wendel’s insights in the session: Sector in focus: Ophthalmology at HBI 2024. In this Healthcare Business International exclusive interview, Dr. Wendel discusses how Sanoptis adds value for its partners, the group’s strategic focus on expanding into new markets, and the synergies created through their innovative partnership model. He also shares insights on the future of ophthalmology, touching on advancements in technology, the increasing role of AI, and promising treatments for conditions like dry age-related macular degeneration.

Read Wendel’s full interview below to learn more about the discoveries and insights of the untapped potential for improving people’s lives with ophthalmology.